| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 19.264.343 $ | 95,14 | 9.964.789 | |||||||
| Relmada Therapeutics Inc. | Relmada Therapeutics Inc. COM | EC | 75955J402 | Long | Börsenkurs (Stufe 1) | 2.059.269 $ | 10,17 | 295.872 | |
| ATAIBECKLEY INC | Ataibeckley Inc. COM SHS | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 2.009.258 $ | 9,92 | 567.587 | |
| DEFINIUM THERAPEUTICS INC | Definium Therapeutics Inc. COM SHS | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 1.725.589 $ | 8,52 | 91.301 | |
| Compass Pathways plc | Compass Pathways plc SPONSORED ADS | EC | 20451W101 | Long | Börsenkurs (Stufe 1) | 1.364.467 $ | 6,74 | 246.739 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc COM | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 944.576 $ | 4,66 | 7.170 | |
| Gh Research Plc | Gh Research Plc ORDINARY SHARES | EC | IE000GID8VI0 | Long | Börsenkurs (Stufe 1) | 942.498 $ | 4,65 | 67.034 | |
| Cybin Inc | Cybin Inc COM NEW | EC | 23256X407 | Long | Börsenkurs (Stufe 1) | 938.899 $ | 4,64 | 195.604 | |
| Alkermes PLC | Alkermes PLC SHS | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 932.408 $ | 4,60 | 26.369 | |
| Johnson & Johnson | Johnson & Johnson COM | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 923.494 $ | 4,56 | 3.778 | |
| Alto Neuroscience Inc | Alto Neuroscience Inc COM SHS | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 922.197 $ | 4,55 | 41.023 | |
| Bright Minds Biosciences Inc | Bright Minds Biosciences Inc COM NEW | EC | 10919W405 | Long | Börsenkurs (Stufe 1) | 920.371 $ | 4,55 | 12.613 | |
| AbbVie Inc. | AbbVie Inc. COM | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 905.846 $ | 4,47 | 4.165 | |
| Supernus Pharmaceuticals, Inc | Supernus Pharmaceuticals, Inc COM | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 902.146 $ | 4,46 | 17.453 | |
| NRX Pharmaceuticals Inc | NRX Pharmaceuticals Inc COM NEW | EC | 629444209 | Long | Börsenkurs (Stufe 1) | 895.595 $ | 4,42 | 420.467 | |
| Neuronetics Inc | Neuronetics Inc COM | EC | 64131A105 | Long | Börsenkurs (Stufe 1) | 894.930 $ | 4,42 | 617.193 | |
| Neuphoria Therapeutics Inc | Neuphoria Therapeutics Inc COM | EC | 64136E102 | Long | Börsenkurs (Stufe 1) | 632.344 $ | 3,12 | 155.367 | |
| Quantum Biopharma Ltd | Quantum Biopharma Ltd CL B SUB VTG SHS | EC | 74764Y205 | Long | Börsenkurs (Stufe 1) | 524.495 $ | 2,59 | 108.591 | |
| PASITHEA THERAPEUTICS CORP | Pasithea Therapeutics Corporation COM NEW | EC | 70261F202 | Long | Börsenkurs (Stufe 1) | 250.363 $ | 1,24 | 337.508 | |
| Silo Pharma Inc | Silo Pharma Inc COM NEW | EC | 82711P201 | Long | Börsenkurs (Stufe 1) | 238.828 $ | 1,18 | 663.965 | |
| VISTAGEN THERAPEUTICS INC | Vistagen Therapeutics Inc. COM | EC | 92840H400 | Long | Börsenkurs (Stufe 1) | 158.368 $ | 0,78 | 277.110 | |
| INCANNEX HEALTHCARE INC | Incannex Healthcare Inc. COM | EC | 45333F208 | Long | Börsenkurs (Stufe 1) | 73.509 $ | 0,36 | 24.503 | |
| Numinus Wellness Inc | Numinus Wellness Inc COM | EC | 67054W103 | Long | Börsenkurs (Stufe 1) | 64.313 $ | 0,32 | 5.359.413 | |
| Enveric Biosciences Inc | Enveric Biosciences Inc COM SHS | EC | 29405E505 | Long | Börsenkurs (Stufe 1) | 32.930 $ | 0,16 | 16.974 | |
| Clearmind Medicine Inc. | Clearmind Medicine Inc. COM SHS | EC | 185053501 | Long | Börsenkurs (Stufe 1) | 7.651 $ | 0,04 | 7.357 | |
| SAGE THERAPEUTICS INC | SAGE THERAPEUTICS INC | EC | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 89.780 | ||
| UNBUZZD WELLNESS INC | Quantum Biopharma Ltd N/C FROM QUANTUM BIOPHARMA LTD TO UNBUZZ | EC | 90429T100 | Long | Börsenkurs (Stufe 1) | 0 $ | 0,00 | 263.236 | |
| QUANTUM BIOPHARMA | QUANTUM BIOPHARMA | EC | Long | Börsenkurs (Stufe 1) | 0 $ | 0,00 | 46.617 | ||
| 19.264.343 $ | 95,14 | 9.964.789 |